Jun 1, 2006 By:
Mike Kelly Pharmaceutical Executive
Doctors aren't the only ones who decide if a patient gets a particular drug. Third-party payers have a say and, increasingly,
so do patients. For nearly a decade, pharma companies have been talking directly to the people who ingest their products.
But the patients aren't always talking back. When the 2005 National Health and Wellness Survey asked patients about their
health, the results were astonishing—particularly when it comes to insomnia and obesity.
Body Mass Index (weight in kilograms divided by the square of height in meters) (kg/m2) BMI is a measure of body fat based on height and weight that applies to both men and women. The National Institute of Health
uses the following categories to interpret BMI.
More than 77 million Americans are obese, and 66 million more are overweight. Nationwide, more than 95 million people report
insomnia or difficulty sleeping. Women have more trouble sleeping than men, but men and women are equally likely to be severely
overweight. Married adults tend to obesity more than single people, while lower-income Americans suffer most often from both
insomnia and obesity.
About the Data In one of the most comprehensive online annual surveys in the world, 41,000 Americans and 36,000 Europeans
fill out detailed questionnaires about their diagnosed and undiagnosed conditions in 75 therapeutic areas. The data here are
drawn from American respondents in 2005, and are weighted by gender, age, race/ethnicity, and education. Staff epidemiologists
projected the sample onto the total US population to create a representative portrait of the American market. Data were validated
through comparisons to the US census and the National Health Interview Survey.
PharmExec Blog
Follow Us
RSS
Bookstore
